In this episode of Navigating the Currents of Change, Shaheen Chohan is joined by Annette Kreuger, IIR’s Senior Vice President of Research for Pharma & Biotech, to explore how Pharmaceuticals and biotech remain two of the most active sectors for global capital investment heading into 2025. From explosive growth in GLP-1 weight-loss drug production to the expansion of biologics and cell & gene therapies, the project pipeline is strong, but not without challenges.
Please Select A Language
*This episode is brought to you by Industrial Info's Latin American Office in Argentina.